"Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders...." Lire la suite
Why digital therapeutics are flourishing under COVID-19
mobihealthnews, 17/09/2020
Partagé par :
Karine Soulat